China Universal Asset Management Co., Ltd. Castle Biosciences Inc Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q2 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Castle Biosciences Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 5,799 shares of CSTL stock, worth $131,753. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,799
Previous 5,719
1.4%
Holding current value
$131,753
Previous $114,000
3.51%
% of portfolio
0.01%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding CSTL
# of Institutions
165Shares Held
27.2MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY3.04MShares$69.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$49.3 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.8MShares$40.9 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.49MShares$33.8 Million2.2% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.38MShares$31.3 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $597M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...